Table 3.
Baseline characteristics of the lipoprotein subfraction analyzed by HPLC.
| Placebo (n = 17) | Policosanol (n = 15) | |||
|---|---|---|---|---|
| Cholesterol | Triglyceride | Cholesterol | Triglyceride | |
| Total, mg/dL | 211.0 ± 21.0 | 81.2 [58.7–96.9] | 207.5 ± 15.5 | 92.9 [67.0–127.2] |
| Large CM (Fraction 1), mg/dL | 0.09 [0.06–0.16] | 0.28 [0.13–0.72] | 0.13 [0.07–0.23] | 0.28 [0.18–1.22] |
| CM (Fraction 2), mg/dL | 0.07 [0.03–0.12] | 0.45 [0.17–1.02] | 0.08 [0.04–0.17] | 0.54 [0.4–1.79] |
| Largest VLDL (Fraction 3), mg/dL | 0.45 [0.33–0.62] | 2.8 [1.3–5.0] | 0.59 [0.41–1.12] | 3.7 [2.3–9.4] |
| Very Large VLDL (Fraction 4), mg/dL | 1.05 [0.52–1.51] | 9.8 [4.5–13.0] | 1.22 [0.72–3.18] | 11.9 [6.8–21.5] |
| Large VLDL (Fraction 5), mg/dL | 5.8 [5.1–6.7] | 16.5 [9.2–23.1] | 7.5 [5.8–8.5]* | 22.6 [12.0–29.2] |
| Medium VLDL (Fraction 6), mg/dL | 5.3 [4.3–9.0] | 12.7 [8.3–17.1] | 7.3 [5.0–8.7] | 17.0 [12.1–20.0] |
| Small VLDL (Fraction 7), mg/dL | 8.2 [6.3–10.9] | 5.5 [4.7–6.0] | 8.1 [7.1–10.6] | 6.7 [5.1–7.4] |
| Large LDL (Fraction 8), mg/dL | 35.6 ± 5.8 | 8.1 [7.3–10.1] | 33.8 ± 5.9 | 9.1 [7.6–10.3] |
| Medium LDL (Fraction 9), mg/dL | 55.2 ± 5.5 | 7.8 [7.2–9.1] | 53.3 ± 4.6 | 8.5 [7.6–9.4] |
| Medium to small LDL (Fraction 10), mg/dL | 24.5 ± 3.6 | 3.3 [3.0–3.8] | 23.6 ± 3.3 | 3.4 [2.7–4.1] |
| Small LDL (Fraction 11), mg/dL | 7.8 ± 1.1 | 1.00 [0.91–1.21] | 7.4 ± 0.9 | 1.03 [0.87–1.26] |
| Very small LDL (Fraction 12), mg/dL | 1.3 ± 0.3 | 0.23 [0.18–1.28] | 1.2 ± 0.2 | 0.21 [0.19–0.3] |
| Smallest LDL (Fraction 13), mg/dL | 1.2 ± 0.2 | 0.19 [0.17–0.23] | 1.2 ± 0.1 | 0.22 [0.17–0.26] |
| Largest HDL (Fraction 14), mg/dL | 0.9 ± 0.2 | 0.16 [0.14–0.19] | 0.9 ± 0.2 | 0.17 [0.15–0.23] |
| Very Large HDL (Fraction 15), mg/dL | 3.0 ± 1.5 | 0.50 [0.37–0.76] | 3.1 ± 1.4 | 0.69 [0.57–0.9] |
| Large HDL (Fraction 16), mg/dL | 15.1 ± 6.1 | 2.7 [1.9–3.5] | 14.9 ± 6.3 | 3.3 [2.7–4.1] |
| Medium HDL (Fraction 17), mg/dL | 22.0 ± 3.4 | 3.1 [2.7–3.7] | 21.0 ± 3.8 | 4.0 [3.1–5.8]* |
| Small HDL (Fraction 18), mg/dL | 14.9 ± 1.8 | 1.9 [1.5–2.1] | 14.6 ± 1.8 | 2.5 [1.8–3.2] |
| Very Small HDL (Fraction 19), mg/dL | 4.8 ± 0.5 | 0.47 [0.42–0.6] | 4.6 ± 0.6 | 0.64 [0.46–0.94] |
| Smallest HDL (Fraction 20), mg/dL | 1.5 ± 0.1 | 0.56 [0.52–0.64] | 1.5 ± 0.1 | 0.60 [0.56–0.69] |
Values represent the mean ± standard deviation or median with interquartile range. Values of fractions 1–7 of cholesterol and all fractions of triglyceride in both groups were log-transformed prior to analysis. *p < 0.05 vs. cholesterol or triglyceride values in the opposite group. Placebo group, n = 17 and policosanol group, n = 15. CM, chylomicron; VLDL, very low-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; HDL, high-density lipoprotein.